RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
CK Life Sciences Intl (Holdings) - Stock

CK Life Sciences Intl (Holdings) Net Income 2024

CK Life Sciences Intl (Holdings) Net Income

17.25 M HKD

CK Life Sciences Intl (Holdings) Dividend yield

2.19 %

Ticker

775.HK

ISIN

KYG2176J1058

WKN

662762

In 2024, CK Life Sciences Intl (Holdings)'s profit amounted to 17.25 M HKD, a -86.93% increase from the 131.96 M HKD profit recorded in the previous year.

The CK Life Sciences Intl (Holdings) Net Income history

YEARNET INCOME (undefined HKD)
202317.25
2022131.96
2021162.8
2020125.23
2019181.74
2018263
2017258.4
2016252.96
2015218.86
2014263.56
2013229
2012176.3
2011125.8
2010208.6
2009187.1
2008-351.8
2007117
2006102
200512.2
20041.9

CK Life Sciences Intl (Holdings) Aktienanalyse

What does CK Life Sciences Intl (Holdings) do?

CK Life Sciences International (Holdings) Inc (CKLS) is a leading company in the field of life sciences and biotechnology, founded in Hong Kong in 1994. It is a subsidiary of CK Hutchison Holdings, one of the largest conglomerates in Asia. CKLS operates in the business sectors of agricultural sciences, health sciences, and investment. The company has international offices in Australia, the USA, Canada, China, and Europe. The agricultural sciences division of CKLS focuses on research and development of plant-based technologies, including plant breeding, agricultural production, and biological pest control. CKLS specifically engages in the development of breeding techniques that enhance the speed, efficiency, and precision of plant breeding. The goal is to increase agricultural production and reduce the ecological footprint. CKLS also has its own brand of biological plant protection products called ABOUND, which provides protection against pests and diseases. The health sciences division of CKLS encompasses research and development of pharmaceuticals and dietary supplements. The company specializes in the development of dietary supplements made from natural ingredients that are intended to promote health and well-being. An example is the probiotic BioGaia, which is used to support digestive health and treat diarrhea. CKLS also engages in the research of herbal medicine and traditional Chinese medicine. The company has launched its own product line of traditional Chinese medicine, developed based on the millennia-old healing methods of Chinese medicine. The investment division of CKLS focuses on investing in companies and innovations that aim to improve life. For example, CKLS has invested in the US company StemCells, which specializes in the research and development of stem cell transplantation for neurological disorders. Overall, CKLS offers a wide range of products and services aimed at improving people's lives and health. Based on its research and development activities in the biotech industry, the company is working to solidify its leading role in the field of life sciences and biotechnology. In summary, CKLS is a leading company in the field of life sciences and biotechnology, operating in the sectors of agricultural sciences, health sciences, and investment. The company offers a wide range of products and services aimed at improving people's lives and health. CK Life Sciences Intl (Holdings) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding CK Life Sciences Intl (Holdings)'s Profit Margins

The profit margins of CK Life Sciences Intl (Holdings) represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of CK Life Sciences Intl (Holdings)'s financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating CK Life Sciences Intl (Holdings)'s profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

CK Life Sciences Intl (Holdings)'s profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When CK Life Sciences Intl (Holdings)’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about CK Life Sciences Intl (Holdings) Stock

How much profit has CK Life Sciences Intl (Holdings) made this year?

CK Life Sciences Intl (Holdings) has made 17.25 M HKD this year.

How has the profit developed compared to last year?

The profit has increased by -86.93% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does CK Life Sciences Intl (Holdings) publish its earnings?

CK Life Sciences Intl (Holdings) publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of CK Life Sciences Intl (Holdings)?

The profits of CK Life Sciences Intl (Holdings) are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of CK Life Sciences Intl (Holdings)?

You can learn more about the earnings of CK Life Sciences Intl (Holdings) by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does CK Life Sciences Intl (Holdings) pay?

Over the past 12 months, CK Life Sciences Intl (Holdings) paid a dividend of 0.01 HKD . This corresponds to a dividend yield of about 2.19 %. For the coming 12 months, CK Life Sciences Intl (Holdings) is expected to pay a dividend of 0.01 HKD.

What is the dividend yield of CK Life Sciences Intl (Holdings)?

The current dividend yield of CK Life Sciences Intl (Holdings) is 2.19 %.

When does CK Life Sciences Intl (Holdings) pay dividends?

CK Life Sciences Intl (Holdings) pays a quarterly dividend. This is distributed in the months of June, June, June, June.

How secure is the dividend of CK Life Sciences Intl (Holdings)?

CK Life Sciences Intl (Holdings) paid dividends every year for the past 13 years.

What is the dividend of CK Life Sciences Intl (Holdings)?

For the upcoming 12 months, dividends amounting to 0.01 HKD are expected. This corresponds to a dividend yield of 2.19 %.

In which sector is CK Life Sciences Intl (Holdings) located?

CK Life Sciences Intl (Holdings) is assigned to the 'Health' sector.

Wann musste ich die Aktien von CK Life Sciences Intl (Holdings) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CK Life Sciences Intl (Holdings) from 6/5/2023 amounting to 0.008 HKD, you needed to have the stock in your portfolio before the ex-date on 5/23/2023.

When did CK Life Sciences Intl (Holdings) pay the last dividend?

The last dividend was paid out on 6/5/2023.

What was the dividend of CK Life Sciences Intl (Holdings) in the year 2023?

In the year 2023, CK Life Sciences Intl (Holdings) distributed 0.01 HKD as dividends.

In which currency does CK Life Sciences Intl (Holdings) pay out the dividend?

The dividends of CK Life Sciences Intl (Holdings) are distributed in HKD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von CK Life Sciences Intl (Holdings)

Our stock analysis for CK Life Sciences Intl (Holdings) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CK Life Sciences Intl (Holdings) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.